Eisenmenger Reaction: Causes, Symptoms & Treatment

What is the Eisenmenger Reaction?

The Eisenmenger reaction (also known as Eisenmenger syndrome) is a life-threatening complication that can develop as a consequence of certain congenital heart defects. It is characterized by permanently elevated blood pressure in the pulmonary circulation (pulmonary hypertension) that becomes severe enough to reverse the direction of blood flow through the heart defect. As a result, oxygen-poor blood enters the systemic circulation directly, causing the characteristic bluish discoloration of the skin known as cyanosis.

Causes

The Eisenmenger reaction develops as a long-term consequence of untreated or late-treated congenital heart defects in which an abnormal connection exists between the left and right sides of the heart or between the great vessels. The most common underlying conditions include:

• Ventricular septal defect (VSD): A hole in the wall separating the heart ventricles
• Atrial septal defect (ASD): A hole in the wall separating the heart atria
• Patent ductus arteriosus (PDA): An open connection between the aorta and the pulmonary artery that did not close after birth
• Atrioventricular septal defect (AVSD): A combined malformation of the cardiac septa and heart valves

Initially, the heart defect causes too much blood to flow into the pulmonary circulation (left-to-right shunt). This places a persistent strain on the blood vessels in the lungs, leading to progressive thickening and stiffening of the pulmonary vessel walls. Over time, the resistance in the pulmonary vessels increases to such an extent that blood flow reverses (right-to-left shunt) – the Eisenmenger reaction has occurred.

Symptoms

The symptoms of the Eisenmenger reaction typically develop gradually over years or decades. Common manifestations include:

• Cyanosis: Bluish discoloration of the lips, fingernails, and skin due to low oxygen levels in the blood
• Clubbing of fingers and watch-glass nails: Characteristic changes of the fingers caused by chronic oxygen deficiency
• Exertional dyspnea: Shortness of breath during physical activity, and eventually also at rest
• Chronic fatigue and reduced exercise tolerance
• Palpitations or cardiac arrhythmias
• Fainting episodes (syncope)
• Coughing up blood (hemoptysis) in advanced stages
• Increased susceptibility to infections and stroke

Diagnosis

The diagnosis of the Eisenmenger reaction is established through a combination of examinations:

• Echocardiography: Visualization of the heart defect and measurement of pulmonary artery pressure
• Electrocardiogram (ECG): Detection of signs of right heart strain
• Chest X-ray: Assessment of heart size and pulmonary vasculature
• Right heart catheterization: Direct measurement of pulmonary pressure and vascular resistance – considered the gold standard
• Blood gas analysis: Measurement of oxygen content in the blood
• Cardiac CT or MRI: Detailed imaging of cardiac structures and vessels

Treatment

Once fully established, the Eisenmenger reaction cannot be cured. Surgical correction of the underlying heart defect is no longer possible at this stage, as it cannot reverse the pulmonary vascular disease. Treatment therefore focuses on relieving symptoms and slowing the progression of the condition.

Drug Therapy

Modern medications targeting pulmonary hypertension can positively influence the course of the disease and improve quality of life:

• Endothelin receptor antagonists (e.g., bosentan, ambrisentan): Dilate the pulmonary vessels
• Phosphodiesterase-5 inhibitors (e.g., sildenafil, tadalafil): Reduce pulmonary vascular resistance
• Prostacyclin analogues (e.g., iloprost, epoprostenol): Potent vasodilatory effect

General Measures

• Oxygen therapy when significant oxygen deficiency is confirmed
• Regular cardiological follow-up examinations
• Avoidance of intense physical exertion, high-altitude environments, and certain medications
• Vaccination against influenza and pneumococcal infections

Heart-Lung Transplantation

In advanced stages, a combined heart-lung transplantation or lung transplantation combined with simultaneous correction of the heart defect may be considered. However, this option is available only to a small group of patients and carries substantial risks.

Prognosis

Thanks to modern treatment options, many patients today have a significantly better life expectancy than several decades ago. Early diagnosis and treatment of the underlying heart defect during childhood – before the Eisenmenger reaction develops – is of critical importance. Patients with the Eisenmenger reaction should be managed in specialized centers for congenital heart disease and pulmonary hypertension.

References

1. Galie N et al. - 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal, 2016; 37(1): 67-119.
2. Diller GP, Gatzoulis MA - Pulmonary Vascular Disease in Adults with Congenital Heart Disease. Circulation, 2007; 115(8): 1039-1050.
3. Lammers AE et al. - Eisenmenger Syndrome: Clinical Features, Diagnosis, and Current Treatment. Deutsches Arzteblatt International, 2010; 107(40): 699-706.